Whether ahead of their time, truly bizarre, or just plain doomed, it’s certainly interesting to see companies go completely ...

"The trial shows that aspirin is well tolerated in this patient group but does not demonstrate a significant reduction in ...

A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

Nearly 12 months later, green shoots may finally be appearing following a desperately dark time for the German group that invented aspirin. Bayer announced plans earlier this year to secure €2 ...

In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.

Bayer is pressing ahead with a phase 3 trial ... stroke or stent thrombosis compared to placebo – both given alongside aspirin plus a P2Y12 inhibitor – at one year. Once again, there was ...

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...